Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.

Emergency laparotomy in older patients may lead to worse morbidity, mortality

04 Nov 2019

Morbidity and mortality following emergency laparotomy appear to be worse in elderly patients than in those who are relatively younger, and this may be attributed to comorbidities resulting in higher American Society of Anaesthesiology (ASA) physical status classification, a study has shown.

The analysis included 170 emergency laparotomies performed in patients from the National University Hospital, Singapore. Researchers collected demographic data, indication of surgery and surgical procedure. They also evaluated nutritional scores.

Elderly patients had a significantly longer mean stay in hospital (31.5 vs 18.6 days; p=0.006) and mean stay in ICU (13.1 vs 5.3 days; p=0.003) compared with nonelderly patients. Furthermore, elderly patients were more likely to develop postlaparotomy complications (65.8 percent vs. 37.4 percent, p<0.001).

Mortality was also less favourable for elderly vs nonelderly patients, both at 30 days (31.5 percent vs 8.8 percent; p=0.019) and 1 year (27.9 percent vs 14.3 percent; p=0.023).

There were no significant between-group differences observed in the global 3-Minute Nutrition Screening tool and the global subjective global assessment nutritional scores.

ASA status emerged as a significant risk factor for lower survival following emergency laparotomy (hazard ratio [HR], 2.61, 95 percent confidence interval [CI], 1.05–6.45; p=0.038). On univariate analysis, age ≥65 years correlated significantly with survival (HR, 1.03, 95 percent CI, 1.01–1.05; p=0.003), but this effect disappeared following multivariate regression (HR, 1.01, 95 percent CI, 0.453–2.23; p=0.989).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.
11 Jan 2020
Prevention of glucocorticoid-induced osteoporosis (GIOP) and postmenopausal osteoporosis (PMOP) remains inadequate in patients with rheumatoid arthritis (RA), as shown in a study that evaluated the implementation of the 2003 and 2014 French guidelines on the prevention and treatment of GIOP and the 2012 update of the French guidelines for the treatment of PMOP.